Results 201 to 210 of about 100,489 (213)

Virologic and immunologic response to highly active antiretroviral therapy

Current HIV/AIDS Reports, 2002
Highly active antiretroviral therapy (HAART) delays clinical progression by suppressing viral replication, measured by a substantial reduction in HIV RNA, allowing the immune system to reconstitute, measured in most studies by an increase in CD4 cells. These virologic and immunologic consequences do not occur uniformly among HAART users. Markers of HIV
Lisa P., Jacobson, John P., Phair, Traci E., Yamashita   +2 more
openaire   +3 more sources

Factors Affecting Patient Adherence to Highly Active Antiretroviral Therapy

Annals of Pharmacotherapy, 2003
OBJECTIVE: To determine the clinical and demographic variables related to adherence to highly active antiretroviral therapy (HAART) in patients treated in our hospital and identify the characteristics of nonadherent patients. METHODS: Outpatients receiving treatment with HAART (n = 283) were asked about variables related to adherence and to complete ...
Escobar, Ismael, Campo, Mercedes, Martín , Jesús, Fernández-Shaw, Clara, Pulido, Federico, Rubio, Rafael   +5 more
openaire   +3 more sources

Highly active antiretroviral therapy and HIV transmission

The Lancet, 2006
Julio Montaner and colleagues (Aug 5, p 531) postulate that the widespread use of highly active antiretroviral therapy (HAART) can decrease HIV incidence. They argue for a preventioncentred expansion in the use of HAART, and argue that the transmission benefi t is unlikely to be outweighed by increases in sexual risk behaviour. In one of the ecological
openaire   +1 more source

[Highly Active AntiRetroviral Therapy and cryptosporidiosis].

Parassitologia, 2004
In HIV infected persons, Cryptosporidium parvum causes chronic diarrhoea, which can be life-threatening in persons with AIDS and with a low CD4+ T cell count. However, a specific and effective therapy for this opportunistic infection does not yet exist.
openaire   +1 more source

Adherence and Effectiveness of Highly Active Antiretroviral Therapy

Archives of Internal Medicine, 1998
H, Knobel, A, Carmona, S, Grau, J, Pedro-Botet, A, Díez   +4 more
openaire   +2 more sources

Hepatotoxicity after introduction of highly active antiretroviral therapy

AIDS, 1998
R, Rodríguez-Rosado, J, García-Samaniego, V, Soriano   +2 more
openaire   +2 more sources

[Highly active antiretroviral therapy].

MMW Fortschritte der Medizin, 2009
openaire   +1 more source

[Highly active antiretroviral therapy (HAART)].

Osterreichische Krankenpflegezeitschrift, 1999
openaire   +1 more source

Highly Active Antiretroviral Therapy (HAART)

openaire   +1 more source

Cutaneous Manifestations of Highly Active Antiretroviral Therapy

2012
Deborah B. Henderson, Clay J. Cockerell
openaire   +1 more source